Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
The Breast Journal|November 6, 2010
New strategies of mammary cancer vaccinationRoberto S Accolla, Valeria Frangione, Andrea De Lerma Barbaro, et al.
Frontiers in Immunology|May 7, 2019
Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor ProgressionAntonino Bruno, Lorenzo Mortara, Denisa Baci, et al.
Frontiers in Immunology|April 22, 2025
CAR-NK cell therapy: promise and challenges in solid tumorsSahar Balkhi, Gaia Zuccolotto, Anna Di Spirito, et al.
Current Opinion in Pharmacology|June 18, 2017
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?Lorenzo Mortara, Andrew V Benest, David O Bates, et al.
Cancer Medicine|October 25, 2013
Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabineLorenzo Mortara, Paola Orecchia, Patrizia Castellani, et al.
Current Medicinal Chemistry|September 6, 2018
Tumor Vasculature Targeted TNFα Therapy: Reversion of Microenvironment Anergy and Enhancement of the Anti-tumor EfficiencyEnrica Balza, Barbara Carnemolla, Paola Orecchia, et al.
Seminars in Cancer Biology|July 23, 2025
Cancer prevention and interception with antidiabetic and anti-obesity drugs: Current and future perspectivesAdriana Albini, Anna Rita Cantelmo, Lorenzo Mortara, et al.
European Journal of Immunology|February 16, 2017
The therapeutic T-cell response induced by tumor delivery of TNF and melphalan is dependent on early triggering of natural killer and dendritic cellsEnrica Balza, Silvia Zanellato, Alessandro Poggi, et al.
Pageof 9